Publikationen, an denen er mitarbeitet MONICA GARCIA ALLOZA (20)

2022

  1. Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes

    Fluids and Barriers of the CNS, Vol. 19, Núm. 1

  2. Caffeine Restores Neuronal Damage and Inflammatory Response in a Model of Intraventricular Hemorrhage of the Preterm Newborn

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. Alzheimer’s disease and diabetes: Role of diet, microbiota and inflammation in preclinical models

    Biomolecules, Vol. 11, Núm. 2, pp. 1-25

  2. Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer’s Disease and Type 2 Diabetes

    Frontiers in Aging Neuroscience, Vol. 13

2020

  1. Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer's mouse model

    Journal of Neuroinflammation, Vol. 17, Núm. 1

  2. Cell proliferation and neurogenesis alterations in Alzheimer’s disease and diabetes mellitus mixed murine models

    Journal of Neurochemistry, Vol. 154, Núm. 6, pp. 673-692

  3. Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes

    Alzheimer's Research and Therapy, Vol. 12, Núm. 1

  4. Erythropoietin Improves Atrophy, Bleeding and Cognition in the Newborn Intraventricular Hemorrhage

    Frontiers in Cell and Developmental Biology, Vol. 8

2019

  1. Altered plasma-type gelsolin and amyloid-β in neonates with hypoxic-ischaemic encephalopathy under therapeutic hypothermia

    Journal of Cerebral Blood Flow and Metabolism, Vol. 39, Núm. 7, pp. 1349-1354

  2. Review of the effect of natural compounds and extracts on neurodegeneration in animal models of diabetes mellitus

    International Journal of Molecular Sciences, Vol. 20, Núm. 10

2018

  1. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer’s Disease and Type 2 Diabetes

    Molecular Neurobiology, Vol. 55, Núm. 7, pp. 6130-6144

  2. Cognitive Impairment and Brain and Peripheral Alterations in a Murine Model of Intraventricular Hemorrhage in the Preterm Newborn

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 4896-4910

2017

  1. Intranasal insulin reverts central pathology and cognitive impairment in diabetic mother offspring

    Molecular Neurodegeneration, Vol. 12, Núm. 1

  2. Long-Term Mangiferin Extract Treatment Improves Central Pathology and Cognitive Deficits in APP/PS1 Mice

    Molecular Neurobiology, Vol. 54, Núm. 6, pp. 4696-4704

  3. Mango leaf extract improves central pathology and cognitive impairment in a type 2 diabetes mouse model

    Brain Pathology, Vol. 27, Núm. 4, pp. 499-507

2016

  1. Increased Spontaneous Central Bleeding and Cognition Impairment in APP/PS1 Mice with Poorly Controlled Diabetes Mellitus

    Molecular Neurobiology, Vol. 53, Núm. 4, pp. 2685-2697

  2. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes

    Psychoneuroendocrinology, Vol. 65, pp. 15-25

2015

  1. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease

    Psychoneuroendocrinology, Vol. 62, pp. 69-79

  2. Prediabetes and type 2 diabetes implication in central proliferation and neurogenesis

    Neural Regeneration Research

2014

  1. Prediabetes-induced vascular alterations exacerbate central pathology in APPswe/PS1dE9 mice

    Psychoneuroendocrinology, Vol. 48, pp. 123-135